IL1B and atherosclerosis: For example, van der Heijden et al. reported that intraperitoneal administration of MCC950 significantly ameliorates the development of atherosclerosis in Apoe−/− mice, and is associated with reduced plasma IL-1β levels and reduced macrophages in the lesions [456].